|
| Status |
Public on Dec 07, 2020 |
| Title |
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
33436641 |
| |
| Submission date |
Nov 12, 2020 |
| Last update date |
Mar 08, 2021 |
| Contact name |
Priyankara J Wickramasinghe |
| E-mail(s) |
priyaw@wistar.org
|
| Phone |
2154956837
|
| Organization name |
The Wistar Institute
|
| Department |
Bioinformatics
|
| Lab |
Genomics
|
| Street address |
3601 Spruce Street
|
| City |
Philadelphia |
| State/province |
PA |
| ZIP/Postal code |
19104 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
| Samples (12)
|
| GSM4885524 |
Spleen from tumor-bearing humanized mice 2 |
| GSM4905188 |
Control tumor from Hu-mice [Tc1] |
| GSM4905189 |
Control tumor from Hu-mice [Tc2] |
| GSM4905190 |
Anti-PD-1 treated tumor from Hu-mice [T1] |
| GSM4905191 |
Anti-PD-1 treated tumor from Hu-mice [T2] |
| GSM4905192 |
Anti-PD-1 treated tumor from Hu-mice [T3] |
| GSM4905193 |
Anti-PD-1 treated tumor from Hu-mice [T4] |
| GSM4905194 |
Anti-PD-1 treated tumor from Hu-mice [T5] |
| GSM4905195 |
Anti-PD-1 treated tumor from Hu-mice [T6] |
|
| This SuperSeries is composed of the following SubSeries: |
| GSE160885 |
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. [TCR] |
| GSE161351 |
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. [RNA-Seq] |
|
| Relations |
| BioProject |
PRJNA677941 |
Less...
More...